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Abstract
Background: Paris polyphylla is an oriental folk medicine that has anticancer activities both in vivo and in vitro.
Polyphyllin VII (PP7), a pennogenyl saponin from P. polyphylla has been found to exert strong anticancer activity.
However, the underlying mechanisms are poorly understood. In the present study, the anticancer effect of
polyphyllin VII against human liver cancer cells and the molecular mechanisms were investigated.
Methods: Cellular viability was measured by MTT assay. Apoptosis, intracellular reactive oxygen species (ROS) and
mitochondrial membrane potential levels were evaluated using the InCell 2000 confocal microscope. The
expression levels of apoptotic-related proteins were evaluated by Western blotting.
Results: PP7 strongly inhibited the cell growth and induced apoptosis and necrosis in hepatocellular
carcinoma HepG2 cells. Meanwhile, PP7 up-regulated the levels of Bax/Bcl-2, cytochrome c, the cleaved forms
of caspases-3, -8, -9, and poly (ADP-ribose) polymerase in a dose- and time-dependent manner, indicating that PP7
induced apoptosis in HepG2 cells through both intrinsic and extrinsic pathways. Moreover, PP7 provoked the
production of intracellular ROS and the depolarization of mitochondrial membrane potential. Further analysis showed
that PP7 significantly augmented the phosphorylation of JNK, ERK and p38, the major components of
mitogen-activated protein kinase (MAPK) pathways, and the expressions of tumor suppressor proteins p53 and
PTEN. In addition, PP7-induced apoptosis was remarkably attenuated by MAPK inhibitors and ROS inhibitor.
Conclusions: These results demonstrated that PP7 induced apoptotic cell death in HepG2 cells through both
intrinsic and extrinsic pathways by promoting the generation of mitochondrial-mediated ROS and activating
MAPK and PTEN/p53 pathways.
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Background
Cancer is one of the leading causes of death in the world
and affects millions of patients worldwide despite signifi-
cant advances have been made in the prevention,
diagnosis, and treatment of cancers in recent years [1].
Hepatocellular carcinoma (HCC) is one of the most
common cancers worldwide, ranging from 500,000 to 1
million new cases every year. Liver transplantation and
surgical resection are the most efficient therapeutic
strategies for early stage of HCC. However, current
conventional therapies are still not effective to treat
patients of advanced HCC [2]. Hence, it is imperative to
develop novel therapeutic drugs with high efficiency and
low toxicity for HCC. In recent years, traditional
Chinese medicine (TCM) has been increasingly applied
in HCC prevention and treatment due to the advantages
of safety and lower drug resistance [3, 4]. Studies have
shown that TCM possessed prophylactic and curative
effects on human HCC with multiple actions and
mechanisms [4, 5].
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There are two major types of cell death: necrosis and
apoptosis. Necrotic cell death is commonly a result of
pathological process and often stimulates local or systemic
inflammation. In contrast, apoptosis, a programmed cell
death, is usually a physiological event that does not
provoke inflammation [6]. Therefore, apoptosis was con-
sidered a potent therapeutic target for cancer treatment to
reduce possible adverse side effects [7]. Numerous studies
have demonstrated that apoptosis can be triggered by
diverse pro-apoptosis stimuli converging on mitochondria,
causing mitochondrial depolarization, cytochrome c re-
lease, caspase enzymes activation and eventually apoptotic
cell death [8]. A number of signaling pathways including
caspase cascade and mitogen-activated protein kinase
(MAPK) pathways play a vital role in the process of apop-
tosis. Additionally, tumor suppressor proteins, such as
phosphatase and tensin homolog (PTEN) and p53, are
also important in promoting apoptosis. PTEN is one of
the most frequently mutated, deleted, or silenced tumor
suppressor genes in cancers. It regulates p53 transcrip-
tional activity and protein levels [9]. Studies indicated that
p53 induced apoptosis by either increasing transcriptional
activity of pro-apoptotic genes or suppressing the activity
of the anti-apoptotic genes [10]. Many findings have
demonstrated that PTEN and p53 played a critical role in
DNA damage response and regulated cell cycle and
apoptosis [11, 12].
Recently, a number of natural steroidal saponins
isolated from herbs display potential roles as apoptosis-
promoting agents in a number of cancer cells [13–15],
which have received increased attentions due to their
unique properties. Pro-oxidant-induced apoptosis results
in an increase in intracellular reactive oxygen species
(ROS) formation, which was closely coupled with a
number of downstream events in apoptosis. It is well
known that relatively high level of ROS induces redox
imbalance, causes cell apoptosis or necrosis during
physiological and pathological progress of many diseases.
Tumor cells with higher level of ROS tend to be killed
more easily than normal cells with lower level of ROS.
Therefore, we could explore new anticancer drugs with
high potential in promoting ROS production. Some ster-
oidal saponins have been reported to exert pro-oxidant
actions [16, 17], which may be an important mechanism
for their anticancer and apoptosis-inducing properties.
The rhizome of Paris polyphylla var. yunnanensis, or
called Rhizoma Paridis, a long been used herb in TCM,
possesses multiple pharmacological activities [18]. Not-
ably, it has been used in combination with other herbs to
treat cancer in clinical application of TCM [19]. Several
saponins with significantly biological activities have been
isolated and identified from Rhizoma Paridis and the
steroidal saponins have been reported to have anticancer
effects on many human cancer cell lines [20, 21].
Polyphyllin VII (PP7), one of the steroidal saponins
from Paris polyphylla, has been found to show strong
anticancer activity, as indicated by suppressing the
growth of human cervical cancer HeLa cells [22] and
colorectal cancer cells [23]. However, the underlying
mechanisms of its anticancer activity are largely un-
known. In this study, we aimed to investigate the anti-
cancer effect of PP7 on human liver cancer HepG2 cells
and the underlying molecular mechanisms. We found
that PP7 induced apoptosis in HepG2 cells by inducing
mitochondrial-mediated ROS generation and activating
MAPK and PTEN/p53 pathways.
Methods
Reagents and antibodies
Polyphyllin II, VI and VII were kindly provided by Prof.
Zhinan Mei (South-Central University for Nationalities).
Dulbecco’s modified Eagle’s medium (DMEM) and
Roswell Park Memorial Institute (RPMI) 1640 were
obtained from Gibco (Carlsbad, CA, USA). Fetal calf
serum (FCS) was obtained from Tianhang Biotech
(Hangzhou, Zhejiang, China). Annexin V-fluorescein
isothiocyanate (FITC) Apoptosis Detection Kit, mito-
chondrial membrane potential assay kit 5,5′,6,6′-tetra-
chloro-1,1′,3,3′-tetra-ethyl-benzimidazol-carbocyanine
iodide (JC-1), Hoechst 33342 staining kit, SP600125,
SB203580, and PD98059 were purchased from Beyotime
(Nanjing, Jiangsu, China). 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) was obtained
from Molecular Probes (Eugene, OR, USA). 2′,7′-
dichlorodihydrofluorescein diacetate (DCFH-DA) and
N-acetyl-L-cysteine (NAC) were purchased from
Sigma-Aldrich Co. LLC (Shanghai, China). Primary
antibodies against Bcl-2, Bax, cytochrome c, p-BAD,
BAD, p-stat3, stat3, p-PTEN, PTEN, extracellular
signal-regulated kinase (ERK), p-ERK, p38 MAPK
(p38), p-p38, c-Jun N-terminal kinase (JNK), p-JNK,
p53, cleaved caspase-3, -8, -9 and poly (ADP-ribose)
polymerase (PARP) and glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH), and secondly antibodies were
purchased from Cell Signaling Technology (Danvers, MA,
USA) or Proteintech Group Inc (Wuhan, Hubei, China).
The enhanced chemiluminescence (ECL) detection kit
was obtained from Amersham Pharmacia Biotech
(Buckinghamshire, UK). All other chemicals of analyt-
ical grade were purchased from local sources.
Cell culture and treatments
Human hepatocellular carcinoma cell lines HepG2,
Hep3B and Bel7402, human lung carcinoma cell line
A549, human breast adenocarcinoma cell line MCF-7,
human colorectal adenocarcinoma cell line Caco-2, and
human ovarian carcinoma cell line SKOV-3 were obtained
from American Type Culture Collection (Manassas, VA,
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USA). Human hepatocellular carcinoma cell line SMMC-
7721 was obtained from the Cell Bank of Shanghai Insti-
tute of Biochemistry and Cell Biology, Chinese Academy
of Sciences (Shanghai, China). Cells were grown as mono-
layers in RPMI 1640 or DMEM. Cells were supplemented
with 10 % heat-inactivated FCS, and 100 units/mL
penicillin-streptomycin (Caco-2 cells plus 4 mM glutam-
ine and 1 % nonessential amino acids), and incubated at
37 °C in a humidified atmosphere containing 5 % CO2.
For all in vitro assays, PP7 was dissolved in dimethyl
sulfoxide (DMSO) to make a stock solution, sterilized
using a sterile 0.22 μm membrane filter and stored
at -80 °C, at a final DMSO concentration of less
than 0.1 %. The working solutions were freshly di-
luted in the basal medium.
Cell viability assay
The cytotoxicity of PP7 was measured using MTT
colorimetric assay. Briefly, cells (1 × 104 cells/well) were
seeded in 96-well plates. After complete adhesion, differ-
ent dilutions of PP7 were added and incubated further
for 24, 48 and 72 h. The treated cells were then incu-
bated in freshly DMEM medium containing MTT
(0.2 mg/mL) at 37 °C. After 4 h, the supernatants were
discarded carefully and added DMSO to dissolve the
formazan crystals. The absorbance at 570 nm was
measured with a microplate reader (BioTek, Winooski,
VT, USA). The relative viability of treated cells was
expressed as percentage of control untreated cells.
Determination of apoptosis and necrosis
Apoptosis was determined by visualizing surface exposure
of phosphatidylserine using annexin V-FITC [24]. HepG2
cells were either treated with different concentrations of
PP7 or left untreated as control for 24 h. Cells were then
resuspended in 500 μL binding buffer and incubated with
FITC-conjugated annexin V (0.25 μg/mL), Hoechst 33342
(10 μg/mL) and propidium iodide (3 μg/mL)/RNase
(30 μg/mL) for 15 min at 37 °C in the dark. After supravi-
tal staining, the cells were immediately visualized using
the InCell 2000 confocal microscope (GE Biosciences,
Piscataway, NJ, USA). Each well was taken at least six
images (original magnification × 20). Images were cap-
tured by visualizing blue fluorescence (Hoechst 33342),
green fluorescence (Annexin-V) and red fluorescence
(propidium iodide). The number of positive cells per well
was counted using the software modules supplied with the
InCell 2000 and was expressed relative to the total
number of nuclei present.
Measurement of intracellular reactive oxygen species
(ROS)
The intracellular ROS generation was detected using an
oxidant sensitive fluorescent probe DCFH-DA. To test
the effect of time-dependent ROS generation, HepG2
cells seeded in 96-well plates (1 × 104/well) were treated
with PP7 at the concentration of 1.32 μM for 3, 6, 12
and 24 h, respectively. To test the effect of
concentration-dependent ROS generation, cells were
treated with PP7 of 0.59, 0.88, 1.32 and 1.98 μM for
24 h. After treatment with DCFH-DA for 30 min at 37 °
C in the dark, the cells were washed three times with
phosphate buffered saline and fluorescence images of
the cells were acquired using the InCell 2000 confocal
microscope. For quantitative evaluation of intracellular
ROS production efficacy, the fluorescence was measured
by the software modules supplied with the InCell 2000.
Measurement of mitochondrial membrane potential
(ΔΨm)
The mitochondrial membrane potential was measured
using JC-1, which is a mitochondria-specific lipophilic
cationic fluorescence dye and is capable of selectively
entering the mitochondria. HepG2 cells were plated in a
96 well plate at a density of 1 × 104 cells/well and grown
for 24 h. Different concentrations of PP7 were added
and incubated further for 24 h. HepG2 cells were then
stained with JC-1 working solution for 20 min at 37 °C
in the dark, washed twice with 100 μL JC-1 binding buf-
fer, and placed in growth media. Plates were then imaged
live with the InCell 2000 confocal microscope. Quantita-
tive image analysis was carried out using the software
modules supplied with the InCell 2000.
Determination of the expression levels of apoptotic- and
MAPK-Related Proteins
For Western blotting analysis, HepG2 cells of different
treatment groups were collected. Proteins were extracted
with radio immunoprecipitation assay lysis buffer and
separated using 8-12 % sodium dodecylsulfate polyacryl-
amide gel electrophoresis, and electrotransferred to
polyvinylidene fluoride membranes. The membranes
were blocked with 5 % non-fat milk and incubated
overnight at 4 °C with primary antibodies followed by
incubation with the corresponding secondary antibodies.
Signals were developed using an ECL detection kit accord-
ing to the manufacturer’s instructions. Densitometric
measurement of band intensity was performed with Image
Lab Software (Bio-Rad, Hercules, CA, USA). The expres-
sion of GAPDH was used as an internal standard.
Inhibitor treatment
To clarify the roles of signaling pathways in PP7-
induced apoptosis in HepG2 cells, the cells were
pretreated with the following inhibitors individually
before the treatment of PP7 (1.32 μM): 20 μM SP600125
(JNK specific inhibitor), 5 μM PD98059 (ERK specific
inhibitor), 20 μM SB203580 (p38 specific inhibitor), or
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10 μM NAC (a free radical scavenger). The cells were
then subjected to the determination of apoptosis by
annexin V-FITC staining and measurement of apoptosis-
related protein expression by Western blotting as de-
scribed above.
Statistical analysis
All data were given as the means ± standard deviation
(SD) for at least three independent experiments, and
analyzed for statistical significance using one-way
analysis of variance, followed by Tukey post hoc analysis
using GraphPad Prism 5 software package (GraphPad
Software, San Diego, CA, USA). A p-value < 0.05 was
considered to be statistically significant.
Results
Cytotoxic effect of PP7 on human cancer cells
To examine the cytotoxicity of PP7, five human cancer
cell lines (MCF7, Caco2, SKOV3, A549 and HepG2)
were exposed to PP7 at different concentrations for 24 h
before MTT assay. The results showed that PP7 signifi-
cantly inhibited the growth of all cell lines, with 50 %
inhibitory concentration (IC50) values in the range from
1.32 to 2.70 μM. HepG2 showed the highest sensitivity
to PP7 among these five cancer cell lines, with an IC50
value of 1.32 ± 0.04 μM (Additional file 1). We also
tested the cytotoxic effects of other two steroidal
saponins from Paris polyphylla, Polyphyllin II (PP2) and
Polyphyllin VI (PP6). Both of them exhibited strong
cytotoxic activity against a panel of human cancer cells
(Additional files 2 and 3). Comparing to PP2 and PP6,
PP7 demonstrated the highest cytotoxicity on the tested
cell lines. Therefore, we further investigated the anti-
cancer effects of PP7 on liver cancer cells and the
underlying mechanisms.
Liver cancer cell lines HepG2, Hep3B, Bel7402 and
7721 cells were treated with PP7 at concentrations from
0.17 μM to 10 μM for 24, 48, and 72 h. As indicated in
Table 1, PP7 showed the highest cytotoxicity against
HepG2 cells than the other liver cancer cells, suggesting
its potential selective cytotoxicity to cancer cell lines. In
addition, prolonged exposure of these cells to PP7
resulted in an increased growth inhibitory effect, indicat-
ing that the in vitro anticancer activity of PP7 was in a
time-dependent manner (Table 1). Since HepG2 cell line
was the most sensitive to the treatment of PP7 among
the tested liver cancer cell lines, we chose HepG2 cell
line for the subsequent study.
PP7 induced apoptosis and necrosis in HepG2 cells
We next investigate whether the cytotoxicity of PP7 on
HepG2 cells is related to the induction of apoptosis and
necrosis. Apoptosis and necrosis were determined by
Hoechst/Annexin-V/PI triple staining and InCell 2000
confocal microscope after treatment of HepG2 cells with
PP7 for 24 h. Characteristic examples of our observa-
tions and quantitative image analysis are shown in Fig. 1a
and b. As for the apoptotic cells, they can be stained
with Annexin-V-FITC and were characterized by a green
fluorescence in PP7-treated cells in a dose-dependent
manner (Fig. 1a). The percentage of apoptosis in HepG2
cells treated with 0.88, 1.32 and 1.98 μM of PP7 was
13.3, 19.2 and 40.0 %, respectively (Fig. 1b). Necrotic
cells can be stained by PI with a red fluorescence were
observed in Fig. 1a. The percentage of necrosis in
HepG2 cells was 5.6, 12.5 and 28.7 %, individually
corresponding to 0.88, 1.32 and 1.98 μM of PP7 treat-
ment (Fig. 1b). Meanwhile, HepG2 cells treated with
various concentrations of PP7 presented different de-
grees of cell growth inhibition detected by a blue fluor-
escence staining of nuclei with Hoechst 33342, which
was consistent with the result shown in Table 1.
Effects of PP7 on mitochondrial membrane potential
(ΔΨm) and intracellular ROS in HepG2 cells
JC-1 staining was applied to detect changes in the mito-
chondrial membrane potential of HepG2 cells. As shown
in Fig. 2a, a red fluorescence represents normal mitochon-
dria in vehicle-treated cells, whereas a green fluorescence
represents depolarized mitochondria in PP7-treated cells.
The ratios of JC-1 green-to-red fluorescence intensities
were increased by 54.2, 101.6 and 115.3 % when HepG2
cells were treated with 0.59, 0.88 and 1.32 μM of PP7 for
24 h (Fig. 2b). These results revealed that PP7 could
increase mitochondrial membrane permeability and cause
mitochondrial dysfunction of HepG2 cells, indicating that
the induction of apoptosis in HepG2 cells by PP7 was
through the mitochondrial pathway.
Several studies have shown that the apoptosis induced
by saponins is associated with ROS generation in cells
[16, 17]. Therefore, we next determine whether PP7
could promote ROS generation in HepG2 cells. DCFH-
DA would be hydrolyzed to dichlorofluorescein (DCF)
in the cell and yield a highly green fluorescent signal in
Table 1 Cytotoxicity of Polyphyllin VII (PP7) against human liver
cancer cells (HepG2, Hep3B, Bel7402 and 7721). Cells were
treated with increasing concentrations of PP7 for 24, 48 and
72 h and cell viability was determined by MTT assay as
described in Methods section. Each IC50 value represents means
± SD of 3 to 5 independent experiments
Cell line IC50 (μM)
24 h 48 h 72 h
HepG2 1.32 ± 0.04 0.85 ± 0.03 0.78 ± 0.04
Hep3B 2.61 ± 0.08 1.84 ± 0.06 1.23 ± 0.05
Bel7402 2.86 ± 0.15 1.74 ± 0.06 1.12 ± 0.04
7721 2.30 ± 0.09 1.73 ± 0.05 1.28 ± 0.05
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the presence of intracellular ROS. Quantitative ana-
lysis found that PP7 could rapidly increase the fluor-
escence intensity, indicating an increase in ROS level
in HepG2 cells compared with the control group
(Fig. 2e and f ). The mean intracellular DCF fluores-
cence intensity was increased by 190.5 % in cells
treated with 1.32 μM of PP7 for 24 h (Fig. 2c and e).
A significant increase in ROS was observed at 3 h,
while a peak value appeared at 24 h after PP7 treat-
ment (Fig. 2d and f ). To further determine the role
of ROS production in the process of apoptosis in
HepG2 cells induced by PP7, the cells were pretreated
with 10 μM NAC (a free radical scavenger) for 2 h
and subsequently treated with 1.32 μM PP7 for 24 h.
The induction of apoptosis and necrosis was assessed
by Hoechst/Annexin-V/PI triple staining and InCell
2000 confocal microscope. Figure 5b and c showed
that pretreatment with NAC significantly decrease the
apoptosis and necrosis in PP7-treated HepG2 cells.
These results indicated that PP7 caused oxidative
stress in HepG2 cells and ROS production plays an
important role in PP7-induced apoptosis.
Fig. 1 Polyphyllin VII (PP7) induced apoptosis and necrosis in HepG2 cells. a HepG2 cells were treated with indicated concentrations of PP7 for
24 h and photographed using the InCell 2000 confocal microscope after Hoechst 33342 (blue), Annexin V (green) and PI (red) staining. b The
number of cells displaying intact cells, apoptotic cells or dead cells was counted, * p < 0.05, ** p < 0.01, versus control (CTL). Data are represented
as means ± SD from 3 independent experiments
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Effects of PP7 on the expression of apoptosis-related
proteins in HepG2 cells
In order to explore the mechanisms underlying PP7
induced apoptosis, the expression of apoptosis-related
proteins in HepG2 cells was investigated by Western
blotting. Compared to the vehicle-treated control group,
the expression level of cleaved caspases-3, -8, -9 and
PARP increased by 34 %, 129 %, 65 % and 241 %, re-
spectively, in HepG2 cells treated with 1.98 μM of PP7
for 24 h. Meanwhile, the expression of pro-apoptotic
protein Bax and cytochrome c were increased while
the anti-apoptotic protein Bcl-2 and phosphorylated
Bcl2-associated agonist of cell death (BAD), an anti-
apoptotic form of BAD protein, were suppressed by PP7.
The effects of PP7 on the expression of apoptosis-related
proteins in HepG2 cells were in an obvious time- and
dose-dependent manner (Fig. 3). These data suggested
that PP7 induced apoptosis in HepG2 cells through
intrinsic and extrinsic apoptotic pathways depending
on caspase activation.
Fig. 2 Effects of Polyphyllin VII (PP7) on mitochondrial membrane potential and intracellular reactive oxygen species (ROS) in HepG2 Cells. a
HepG2 cells were treated with indicated concentrations of PP7 for 24 h and photographed using the InCell 2000 confocal microscope after JC-1
staining. b Quantitative analysis of green (FITC)/red (CY3) fluorescence in HepG2 cells, ** p < 0.01, compared to control (CTL). Observation of
intracellular ROS generation by DCFH-DA staining in HepG2 cells after treated with indicated doses of PP7 for 24 h (c, e) or treated with 1.32 μM
PP7 for different times (d, f). ** p < 0.01, compared to CTL. Data are both represented as means ± SD from 3 independent experiments
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Effects of PP7 on the expression of PTEN, p53 and STAT3
in HepG2 cells
We next tested whether the tumor suppressors PTEN and
p53 and their potential downstream target STAT3 [11, 12,
25] were involved in PP7-induced apoptosis in HepG2
cells. As shown in Fig. 4, total protein levels of PTEN and
p53 were increased by 67 % and 114 %, while the phos-
phorylation of STAT3 decreased by 90 % in HepG2 cells
exposed to 1.98 μM of PP7 for 24 h, suggesting that PP7-
induced apoptosis in HepG2 cells might be mediated
through upregulation of PTEN and p53 expression, and
downregulation of STAT3 activation.
PP7 induces apoptosis of HepG2 cells via MAPK pathways
As shown in Fig. 4, the phosphorylation of JNK, ERK
and p38, the major components of MAPK signaling
pathways, was significantly increased in HepG2 cells
treated with PP7 in a dose-dependent manner. To
further exam the role of MAPKs in PP7-induced apop-
tosis in HepG2 cells, JNK inhibitor SP600125 (20 μM),
ERK inhibitor PD98059 (5 μM) and p38 inhibitor
SB203580 (20 μM) were used to pretreat HepG2 cells
before the treatment of PP7. As shown in Fig. 5a, MAPK
inhibitors could significantly reduce the expression of
apoptosis-related proteins in HepG2 cells and decrease
the apoptosis and necrosis of HepG2 cells treated with
PP7 (Fig. 5b and c). Together, these results indicated that
MAPK signaling pathways might mediate PP7-induced
apoptosis in HepG2 cells.
Discussion
The steroidal saponins isolated from herbs possess struc-
tural diversity and significant anticancer activities [13–15].
In recent years, studies demonstrated that the main
anticancer components of Rhizoma Paridis are steroidal
saponins [20, 21]. Polyphyllin VII (PP7), a steroidal
saponin purified from P. polyphylla has been identified as
a potential anticancer agent in many pharmacological
studies [22, 23]. However, the cellular and molecular
mechanisms for the anticancer activity of PP7 are poorly
understood. In the present study, we found that PP7 could
significantly inhibit the proliferation of a panel of
human cancer cell lines in a dose-dependent manner
(Additional file 1). Among the tested cancer cell lines,
HepG2 was the most sensitive to PP7 treatment (Table 1),
indicating that PP7 exhibited relatively selective anticancer
Fig. 3 Effects of Polyphyllin VII (PP7) on the expression of apoptosis-related proteins in HepG2 cells. HepG2 cells were treated with PP7 in the
indicated concentrations for 24 h (a) or treated with 1.32 μM PP7 for the indicated times (b). The protein levels of apoptosis-related proteins were
determined by Western blotting as described in Methods sections. The indicated number under each band was the fold changes of expression
level compared to that in the control group. GAPDH was used as the internal standard for protein loading
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activity. Considerable studies have shown that natural
compounds isolated from TCM were effective in inhibit-
ing cancer cell proliferation of HCC [4]. Oridonin, from
Isodon rubescens, inhibited the proliferation of HepG2
cells with an IC50 of 41.77 μM for 24 h [26]. The IC50
value of oroxylin A, from Scutellaria baicalensis, was
23.94 μM against HepG2 cells after 24 h treatment [27].
The IC50 of arsenic trioxide after exposure HepG2 cells
for 72 h, was approximately 2.25 μM [28]. In the present
study, PP7 significantly inhibited the growth of HepG2
cells, with an IC50 value as low as 1.32 μM for 24 h treat-
ment, indicating that PP7 exhibits strong cytotoxicity
against HepG2 cells. Induction of apoptosis is regarded as
a novel therapeutic strategy for cancers [6]. Many antican-
cer agents have been reported to induce cell death of
tumor cells by triggering apoptosis [29]. In our results,
PP7 strongly induced apoptotic cell death in HepG2 cells
in a dose-dependent manner as evidenced by Annexin V/
Hoechst 33342 staining (Fig. 1), suggesting that the
anticancer effect of PP7 on HepG2 cells was mediated
through the induction of apoptosis.
Various chemotherapeutic agents exert their antican-
cer effects through inducing the generation of ROS, and
the intrinsic apoptotic pathway is especially susceptible
to ROS. In the present study, the production of intracel-
lular ROS increased remarkably in HepG2 cells treated
with PP7 (Fig. 2c and d), while inhibition of ROS pro-
duction by the antioxidant NAC significantly decreased
the apoptosis (Fig. 5b), suggesting that PP7-induced
apoptosis in HepG2 cells was closely associated with the
production of ROS, which may act as upstream signaling
molecules to initiate mitochondria-mediated cell apoptosis.
ROS is involved in the opening of the mitochondrial
permeability transition pore, depolarization of the mito-
chondrial membrane, and then the release of mitochondrial
pro-apoptotic factors in the process of mitochondria-
mediated apoptosis [30]. In our results, PP7 increased the
ratio of JC-1 green-to-red fluorescence intensity (Fig. 2a),
indicating a decreased ΔΨm and depolarization of the
mitochondrial membrane, further confirmed that PP7
induced an ROS-involved mitochondrial pathway-mediated
apoptosis in HepG2 cells. Similar results were reported that
berberine, an isoquinoline alkaloid isolated from TCM,
exhibited cytotoxicity on L929 murine fibroblast cells was
related to accumulation of intracellular ROS, reduction of
mitochondrial membrane potential, and cell apoptosis [31].
Apoptosis is executed through mitochondrial-mediated
intrinsic and cell death receptor-mediated extrinsic path-
ways, both of which are converged to the cascade activa-
tion of caspase proteases [32]. In the intrinsic pathway,
cytochrome c releases from damaged mitochondria and
causes apoptosome-dependent activation of caspase 9.
This leads to the activation of the executioner caspases 3
[33], and eventually inactivation of PARP [30]. In the
extrinsic pathway, activated initiator caspase-8 by death-
inducing signaling complex also cleaves and activates
caspase-3 and results in apoptotic cell death [34]. Our
results demonstrated that PP7 increased the levels of
cleaved caspases-3, -8, -9 and PARP in a dose- and time-
dependent manner (Fig. 3), indicating that both intrinsic
and extrinsic pathways were involved in the process of
PP7-induced apoptosis in HepG2 cells. Our findings are
Fig. 4 Effects of Polyphyllin VII (PP7) on the MAPK and PTEN/p53 pathways in HepG2 cells. Key proteins in MAPK pathways, PTEN and p53 were
determined by Western blotting analysis after treating the cells with PP7 at indicated concentrations for 24 h. The indicated number under each band
was the fold changes of expression level compared to that in the control group. GAPDH was used as the internal standard for protein loading
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consistent with the previous findings that TCM induced
cancer cell apoptosis through intrinsic and extrinsic
pathways [35, 36].
Increased Bax/Bcl-2 ratio leads to ΔΨm collapse,
cytochrome c release, caspase-3 activation, and eventu-
ally apoptosis [37]. In addition, pro-apoptotic proteins
BAD and Bax are closely associated with the control of
mitochondrial membrane permeability and release of
cytochrome c [38]. Our results showed that PP7 increased
the ratio of Bax/Bcl-2, decreased the level of p-BAD
(an anti-apoptotic form), and caused the release of
cytochrome c from mitochondria in a dose- and time-
dependent manner (Fig. 3), further confirmed that
mitochondrial pathway was involved in PP7-induced
apoptosis in HepG2 cells.
Numerous reports have demonstrated that expression
of apoptosis-related proteins is critically regulated by
tumor suppressor proteins PTEN and p53 in response to
DNA damage [11, 12]. Oxidative stress promotes PTEN
nuclear accumulation, which leads to p53 stabilization
and p53-mediated apoptosis [39]. Furthermore, ROS
could cause DNA damage and then directly activate p53
and initiate apoptosis [40]. In the current study, PP7
significantly increased the expression levels of PTEN
and p53 in HepG2 cells (Fig. 4), suggesting their poten-
tial roles in PP7-induced apoptosis in HepG2 cells. The
upregulation of PTEN and p53 expression could be
promoted by increased intracellular ROS production in
HepG2 cells by PP7, which is in line with previous
reports [41–43].
MAPKs are also the major oxidative stress-sensitive
signal transducing pathways [44] and serve as upstream
signals for the initiation of apoptosis. JNK and p38
MAPK were activated in response to ROS generation
and mitochondrial dysfunction, which are frequently
associated with the induction of apoptosis [45]. Li et al.
[46] reported that the total flavonoids from Arachniodes
exilis induced apoptosis in HepG2 cells through ROS-
mediated MAPK activation and mitochondrial dysfunc-
tion. A novel oleanolic acid derivative induces human
hepatoma cell apoptosis via an ROS/MAPK-dependent
mitochondrial pathway [47]. Our results showed that
Fig. 5 Inhibition of MAPK pathways and ROS production attenuated
PP7-induced apoptosis and necrosis in HepG2 cells. a Effects of JNK
inhibitor SP600125, ERK inhibitor PD98059 and p38 inhibitor SB203580
on the expression of apoptosis-related proteins in PP7-treated cells by
Western blotting analysis. The indicated number under each band was
the fold changes of expression level compared to that in the control
group. GAPDH was used as the internal standard for protein loading.
b Effects of SP600125 (SP) , PD98059 (PD), SB203580 (SB) and NAC on
PP7-induced apoptosis and necrosis tested by Hoechst 33342, Annexin
V and PI staining. c Quantification of apoptotic cells in (b). * p < 0.05, **
p < 0.01, versus control (CTL). Data are represented as means ± SD from
3 independent experiments
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PP7 significantly increased the levels of phosphory-
lated JNK, ERK and p38 in a dose-dependent manner
without affecting the expression of total proteins
(Fig. 4), indicating that these MAPK pathways were
activated in the process of PP7-induced apoptosis in
HepG2 cells. Moreover, MAPK inhibitors decreased
the apoptosis of HepG2 cells (Fig. 5) induced by PP7.
These results demonstrated that activation of ERK,
JNK, and p38 pathways were involved in PP7-induced
apoptosis in HepG2 cells.
The transcription factor STAT3 promotes tumori-
genesis mainly through preventing apoptosis by up-
regulating the expression of apoptosis inhibitors in
several primary human cancers [48], and blockage of
constitutive STAT3 signaling results in the growth
inhibition and apoptosis in cancer cells [49]. Studies
reported that the constitutive activation of STAT3
was often negatively regulated by p53, PTEN, and
MAPK pathways [25, 50]. Our data showed that PP7
significantly decreased the phosphorylated STAT3
level in HepG2 cells (Fig. 4). We supposed that
STAT3 might be inhibited by the upregulated p53,
PTEN, and MAPKs, in which the details need to be
further elucidated.
Conclusion
In summary, we demonstrated that PP7 induced apop-
totic cell death in HepG2 cells through both intrinsic
and extrinsic pathways via triggering mitochondrial-me-
diated ROS generation and activating MAPK and
PTEN/p53 pathways (Fig. 6). This study provides an
insight into the molecular mechanisms of PP7-
induced apoptosis in liver cancer cells and presents
that PP7 may be a novel promising agent for liver
cancer treatment.
Additional files
Additional file 1: Polyphyllin VII (PP7) inhibited the proliferation of
human cancer cells. Cells were treated with increasing
concentrations of PP7 for 24 h and cell viability was determined by
MTT assay as described in Methods sections. Each IC50 value
represents means ± SD of 3 to 5 independent experiments. (TIF 382 kb)
Additional file 2: Polyphyllin II (PP2) inhibited the proliferation of
human cancer cells (HepG2, A549, MCF7, SKOV3, Hep3B, Bel7402
and 7721). Cells were treated with increasing concentrations of PP2
for 24 h and cell viability was determined by MTT assay as
described in Methods sections . Each IC50 value represents means ± SD
of 3 to 5 independent experiments. (TIF 593 kb)
Additional file 3: Polyphyllin VI (PP6) inhibited the proliferation of
human cancer cells (HepG2, A549, MCF7, SKOV3, Hep3B, Bel7402
Fig. 6 Schematic diagram showing the proposed apoptotic signaling pathways triggered by PP7 in HepG2 cells. PP7 treatment leads to the
activation of MAPK (JNK, ERK, and p38) and PTEN/p53 signaling pathways, followed by upregulation of pro-apoptotic proteins and downregula-
tion of anti-apoptotic protein, and eventually causes apoptosis in HepG2 cells
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and 7721). Cells were treated with increasing concentrations of PP6 for
24 h and cell viability was determined by MTT assay as described in
Methods sections. Each IC50 value represents means ± SD of 3 to 5
independent experiments. (TIF 594 kb)
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